Trevor Hallam, Chief Scientific Officer at SUTRO BIOPHARMA, INC. (STRO), sold 4,786 shares at $22.37 ($107K) on 2020-12-28, disclosed to the SEC on 2020-12-29.
Open-market sale of $107k STRO by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.37 | 2,393 | $54K | 50.0% |
| 2 | $22.37 | 2,393 | $54K | 50.0% |
| Total | $22.37 avg | 4,786 | $107K | 100% |
| Filing → |
| STRO | SELL | 2020-11-06 | $251K | — | Filing → |
| STRO | SELL | 2020-09-28 | $10K | — | Filing → |
| STRO | SELL | 2020-08-27 | $9K | — | Filing → |